Beverly Hills, CA (August 20, 2015) - KB Exchange Trust ("KB") announced the acquisition of a building leased to Fresenius Medical Care, located in Lake City, Florida. The newly-constructed dialysis clinic was purchased for $5.624 million and totals approximately 10,400 square feet.

"This clinic is a relocation and expansion facility for Fresenius within the Lake City market," stated Jeff Pori, managing partner for KB Exchange Trust. "We love the new design and believe this facility will serve the community well." "Our investors had a very positive response to our previous Fresenius offerings and we fully expect the same enthusiasm for this property." 

Located in northern Florida, along US Highway 90 and just a mile off of Interstate 75. This Lake City FMC clinic serves all of Columbia County with a population of approximately 70,000 residents and is within two miles from the Lake City Medical Center, a 67-bed general medical and surgical hospital that serves approximately 60,000 people annually.

Publicly traded on the New York Stock Exchange (NYSE:FMS), Fresenius Medical Care is the world's largest provider of dialysis services for chronic kidney diseases. Fresenius has a $25 billion market capitalization with over 100,000 employees and a network of 3,400 dialysis clinics in North America, Europe, Latin America, Asia-Pacific, and Africa. In January 2015, Fresenius was upgraded to "Investment-Grade" credit by Standard and Poor's.

The purchase of the Fresenius Medical Care building in Lake City was KB's sixth acquisition of a property leased to Fresenius Medical Care in the past twelve months.


About KB Exchange Trust

KB Exchange Trust is a sponsor of DST-structured real estate investments, specializing in single-tenant, net-leased properties. The sponsor's experience management team has purchased and closed over $2 billion of fractional ownership properties for its 1031 investor clientele.

KB Exchange Trust DST interests are securities as defined by the Securities and Exchange Act of 1934 and may be sold only to "accredited investors," who meet certain minimum annual income or net worth thresholds. The securities are subject to legal restrictions on transfer and there is no market for resale. These securities are being offered in reliance on an exemption from registration, and neither the U.S. Securities and Exchange Commission nor any other regulatory authority has passed upon the merits of an investment in the securities or passed upon the adequacy or accuracy of the offering materials describing the securities. Investing in securities involves risk, and investors should be able to bear the loss of their investment.

Media Contact:

Holly Silvestri
The Ferraro Group
(702) 367-7771